$1.41
2.17% yesterday
Nasdaq, Oct 31, 09:06 pm CET
ISIN
US0043971052
Symbol
ARAY

Accuray Incorporated Stock price

$1.41
-0.26 15.57% 1M
-0.14 9.03% 6M
-0.57 28.79% YTD
-0.32 18.50% 1Y
-0.63 30.88% 3Y
-1.70 54.66% 5Y
-5.58 79.83% 10Y
-27.06 95.05% 20Y
Nasdaq, Closing price Fri, Oct 31 2025
+0.03 2.17%

Key metrics

Basic
Market capitalization
$155.6m
Enterprise Value
$234.7m
Net debt
$79.1m
Cash
$57.4m
Shares outstanding
112.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.3 | 0.3
EV/Sales
0.5 | 0.5
EV/FCF
negative
P/B
1.9
Financial Health
Equity Ratio
17.3%
Return on Equity
-2.0%
ROCE
2.8%
ROIC
-4.0%
Debt/Equity
1.7
Financials (TTM | estimate)
Revenue
$458.5m | $484.7m
EBITDA
$14.0m | $33.8m
EBIT
$7.8m | $14.0m
Net Income
$-1.6m | $-3.5m
Free Cash Flow
$-1.4m
Growth (TTM | estimate)
Revenue
2.7% | 5.7%
EBITDA
55.4% | 141.6%
EBIT
153.6% | 78.2%
Net Income
89.8% | -117.0%
Free Cash Flow
90.9%
Margin (TTM | estimate)
Gross
32.1%
EBITDA
3.1% | 7.0%
EBIT
1.7%
Net
-0.4% | -0.7%
Free Cash Flow
-0.3%
More
EPS
$0.0
FCF per Share
$0.0
Short interest
3.0%
Employees
987
Rev per Employee
$460.0k
Show more

Is Accuray Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Accuray Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Accuray Incorporated forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Accuray Incorporated forecast:

Buy
90%
Hold
10%

Financial data from Accuray Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
459 459
3% 3%
100%
- Direct Costs 312 312
3% 3%
68%
147 147
3% 3%
32%
- Selling and Administrative Expenses 91 91
1% 1%
20%
- Research and Development Expense 48 48
0% 0%
10%
14 14
55% 55%
3%
- Depreciation and Amortization 6.15 6.15
4% 4%
1%
EBIT (Operating Income) EBIT 7.84 7.84
154% 154%
2%
Net Profit -1.59 -1.59
90% 90%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Accuray Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accuray Incorporated Stock News

Neutral
PRNewsWire
about 5 hours ago
MADISON, Wis. , Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer.
Neutral
PRNewsWire
4 days ago
MADISON, Wis. , Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m.
Neutral
PRNewsWire
12 days ago
Industry Veteran Steve La Neve Named Chief Executive Officer  Suzanne Winter to Retire as President and CEO Company Appoints Steven F. Mayer as Transformation Board Sponsor Chan W.
More Accuray Incorporated News

Company Profile

Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Suzanne Winter
Employees 987
Founded 1990
Website www.accuray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today